Concentra Biosciences offers $3/share + CVR for Acelyrin, outperforming Alumis' bid. Read why I rate SLRN stock a Sell at ...

MultiChoice CEO Calvo Mawela said their teams continue to make great progress on the Canal+ transaction ... the new structure it will adopt if French media giant Canal+’s buyout offer is ...

XPLR is shifting its strategy: no distributions, focus on FCF growth, and discounted valuations. Discover risks, opportunities and expert insights. See more here.

In a major restructuring Seven & i Holdings, parent company of 7-Eleven, said Thursday that Stephen Dacus will become its new ...

Public and private M&A are both key for Germany, but it is fair to say that private deals are still dominating the league ...

Putting its many affairs in order will probably be easier as a private company, but there are still pitfalls — including a ...

If a private equity buyer is exploring an acquisition of the company you manage, and you anticipate remaining involved in the business after the ...

The Swiss M&A market started strong in early 2024, slowed in the third quarter, but picked up again by the end of the year.

Recent high-profile disputes suggest that legal issues in tech M&A are no longer isolated but intricately interdependent.

The Fox and News Corp. titan is locked in a legal feud with his more-liberal children over attempts to consolidate power under Lachlan.